New CRISPR variant Cas12a2 selectively kills cancer cells without harming healthy ones
A paper published in Nature on 6 May 2026 describes a new class of CRISPR tool, Cas12a2, that destroys cells displaying a target RNA signature rather than editing DNA. The mechanism — “RNA-triggered cell killing” — opens a precision-medicine route to cancers and viral infections that has been hard to reach with conventional gene-editing. In […]
